| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690512 | Urology | 2017 | 20 Pages |
Abstract
Plasmacytoid UC is associated with a high rate of locally advanced disease and positive margins at RC, as well as increased local recurrence rates. Further research is necessary to delineate adjuvant or neoadjuvant treatment strategies to improve local cancer control of this rare subtype of UC.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Patrick A. Cockerill, John C. Cheville, Stephen A. Boorjian, Andrew Blackburne, Prabin Thapa, Robert F. Tarrell, Igor Frank,